Search by Drug Name or NDC
NDC 43066-0360-20 Nexterone 1.8 mg/mL Details
Nexterone 1.8 mg/mL
Nexterone is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is AMIODARONE HYDROCHLORIDE.
Product Information
NDC | 43066-0360 |
---|---|
Product ID | 43066-360_b3d4e148-3bc1-4c80-8df7-5006a77c813d |
Associated GPIs | 35400005112030 |
GCN Sequence Number | 067476 |
GCN Sequence Number Description | amiodarone in dextrose,iso-osm PLAST. BAG 360MG/0.2L INTRAVEN |
HIC3 | A2A |
HIC3 Description | ANTIARRHYTHMICS |
GCN | 30043 |
HICL Sequence Number | 037678 |
HICL Sequence Number Description | AMIODARONE IN DEXTROSE, ISO-OSMOTIC |
Brand/Generic | Brand |
Proprietary Name | Nexterone |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | amiodarone hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 1.8 |
Active Ingredient Units | mg/mL |
Substance Name | AMIODARONE HYDROCHLORIDE |
Labeler Name | Baxter Healthcare Corporation |
Pharmaceutical Class | Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA022325 |
Listing Certified Through | 2024-12-31 |
Package
NDC 43066-0360-20 (43066036020)
NDC Package Code | 43066-360-20 |
---|---|
Billing NDC | 43066036020 |
Package | 200 mL in 1 BAG (43066-360-20) |
Marketing Start Date | 2010-11-16 |
NDC Exclude Flag | N |
Pricing Information | N/A |